Skip to main content

Table 1 Baseline characteristics of HIV infected and non-infected women at the time of cervical cancer diagnosis

From: Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting

 

Total

(N = 270)

HIV infected

(N = 123)

HIV non-infected

(N = 147)

Histology

 Squamous Cell Carcinoma

251 (93)

117 (95.1)

134 (91.2)

 Adenocarcinoma

16 (5.9)

4 (3.3)

12 (8.2)

 No histology available

3 (1.1)

2 (1.6)

1 (0.7)

Disease severity stage

 Early stage I-IIA

28 (10.4)

16 (13.0)

12 (8.2)

 Advanced stage IIB-IIIB

152 (56.3)

71 (57.7)

81 (55.1)

 Late stage IV

5 (1.9)

1 (0.8)

4 (2.7)

 Missing information

85 (31.5)

35 (28.5)

50 (34.0)

Age at diagnosis in years, median (range)

49.8 (21–87)

44.8 (21–76)

55.9 (31–87)

Marital Status

 Single

45 (1.9)

3 (2.6)

1 (0.7)

 Married

147 (54.4)

55 (48.3)

87 (59.2)

 Widowed

103 (38.2)

48 (42.1)

52 (35.4)

 Divorced or separated

15 (5.6)

7 (6.1)

7 (4.8)

Pregnancies & Birth

 Gravidity, median (range)

6 (0–23)

4 (0–13)

7 (0–23)

 Parity, median (range)

5 (0–20)

4 (0–12)

6 (0–20)

Education

 No education

106 (39.3)

27 (22)

79 (53.7)

 Basic education

153 (56.7)

89 (72.4)

64 (43.5)

 Advanced education

11 (4.1)

7 (5.7)

4 (2.7)

Antiretroviral treatment (ART)

 On ART

 

88 (71.6)

 

 -Years on ART, median (range)

 

4,5 (0–20)

 

 - < 1 year on ART

 

15 (12.2)

 

 - ≥ 1 year on ART

 

62 (50.4)

 

 Not on ART

 

23 (18.7)

 

 Not known

 

12 (9.8)

 

CD4 Counts

 Recent CD4 count, median (range)

 

365 (11–1226)

 

 - ≤ 200 cells/µl

 

25 (20.3)

 

 -200–349 cells /µl

 

31 (25.2)

 

 - ≥ 350 cells /µl

 

68 (55.3)

 

 Lowest CD4 count, median (range)

 

231 (5–1158)

 

 - < 200 cells /µl

 

48 (39)

 

 CD4 cell count not known

 

5 (4.1)

 

WHO Stages

 Stages 1–2

 

90 (73,2)

 

 Stages 3–4

 

19 (15.5)

 

 Not known

 

14 (11.4)

 

Clinical Presentation

 Any symptoms

249 (92.2)

110 (89,4)

139 (94.6)

 No symptoms

21 (7.8)

13 (10,6)

8 (5.4)

 Lower abdominal pain

177 (65.6)

79 (64,2)

98 (66.7)

 Abnormal vaginal discharge

223 (82.6)

96 (78.1)

127 (86.4)

 Abnormal menstrual bleeding

62 (23)

34 (27.6)

28 (19.1)

 -Intermenstrual bleeding

39 (14.4)

27 (22)

12 (8.2)

 -Prolonged menstrual bleeding

29 (10.7)

10 (8.1)

19 (12.9)

 Sexually active

N = 85

N = 46

N = 39

 -Post-coital bleeding

60 (70.6)

34 (73.9)

26 (66.7)

 -Pain during sex

70 (82.4)

38 (82.6)

32 (82.1)